$4.63
-0.04-0.86%
At Close: -
$4.79
0.163.50%
After Hours: 5:35 PM EDT
15 minutes delayed
Comments
Loading...
Autolus Therapeutics (AUTL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAutolus Therapeutics (NASDAQ:AUTL) Stock Quotes, Forecast and News Summary
Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.
| Open | $4.66 |
| Close | $4.63 |
| Volume / Avg. | 770.27K / 1.61M |
| Day Range | 4.48 - 4.68 |
| 52 Wk Range | 2.01 - 7.45 |
| Market Cap | $1.27B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 68 |
| Short Interest | 6.04% |
| Days to Cover | 6.7 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Autolus Therapeutics plc
Sector
Health Care
Industry
Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Autolus Therapeutics (AUTL) stock?
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Who are Autolus Therapeutics (AUTL) competitors?
Other companies in Autolus Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Prothena Corp (NASDAQ:PRTA).
What is the target price for Autolus Therapeutics (AUTL) stock?
There is no analysis for Autolus Therapeutics.
What is the forecast for Autolus Therapeutics (AUTL) stock?
Autolus Therapeutics has a consensus price target of $8.72.
Current stock price for Autolus Therapeutics (AUTL)?
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $4.7921 last updated July 29, 2024 at 5:35 PM EDT.
Does Autolus Therapeutics (AUTL) pay a dividend?
There are no upcoming dividends for Autolus Therapeutics.
When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?
Autolus Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Autolus Therapeutics (AUTL) going to split?
There is no upcoming split for Autolus Therapeutics.
What sector and industry does Autolus Therapeutics (AUTL) operate in?
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.